Literature DB >> 33545164

Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.

Paul F Pinsky1, Yan Kwan Lau2, Chyke A Doubeni3.   

Abstract

BACKGROUND: Criteria for low-dose CT scan lung cancer screening vary across guidelines. Knowledge of the eligible pool across demographic groups can enable policy and programmatic decision-making, particularly for disproportionately affected populations. RESEARCH QUESTION: What are the eligibility rates for low-dose CT scan screening according to sex and race or ethnicity and how do these rates relate to corresponding lung cancer incidence rates? STUDY DESIGN AND METHODS: This was a cross-sectional study using data from the 2015 National Health Interview Survey adult and cancer control supplement files. In addition to eligibility rates, the ratio of the eligibility rate to the lung cancer incidence rate in a given population group (eligibility to incidence [E-I] ratio) also was determined. Guidelines assessed were: Centers for Medicare and Medicaid Services, National Comprehensive Cancer Network, and US Preventive Services Task Force current or with expansion of age and smoking or quit thresholds. We also assessed a risk model (PLCOM2012 risk model).
RESULTS: Total numbers eligible based on current guidelines ranged from 8.3 to 13.3 million, representing 8.3% to 13.4% of the US population 50 to 80 years of age, and up to 17.5 million with expanded criteria. Overall eligibility rates on average were about 10 percentage points higher for men than women. For both men and women, and both overall and among ever smokers, non-Hispanic Whites had the highest eligibility rates across all guidelines, followed generally by non-Hispanic Blacks, and then Asians and Hispanics. Among both men and women, non-Hispanic Whites had the highest E-I ratios across all guidelines; non-Hispanic Black men had higher lung cancer incidence, but 30% to 50% lower E-I ratios, than non-Hispanic White men.
INTERPRETATION: Screening eligibility rates vary widely across guidelines, with disparities evident in E-I ratios, including among non-Hispanic Black men, despite higher lung cancer burden. Consideration of smoking duration in risk assessment criteria may address current disparities.
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  disparities; eligibles; guidelines; lung cancer; screenings

Mesh:

Year:  2021        PMID: 33545164      PMCID: PMC8411441          DOI: 10.1016/j.chest.2021.01.070

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   10.262


  35 in total

1.  Challenges and Opportunities for Lung Cancer Screening in Rural America.

Authors:  Cassie L Odahowski; Whitney E Zahnd; Jan M Eberth
Journal:  J Am Coll Radiol       Date:  2019-04       Impact factor: 5.532

Review 2.  European position statement on lung cancer screening.

Authors:  Matthijs Oudkerk; Anand Devaraj; Rozemarijn Vliegenthart; Thomas Henzler; Helmut Prosch; Claus P Heussel; Gorka Bastarrika; Nicola Sverzellati; Mario Mascalchi; Stefan Delorme; David R Baldwin; Matthew E Callister; Nikolaus Becker; Marjolein A Heuvelmans; Witold Rzyman; Maurizio V Infante; Ugo Pastorino; Jesper H Pedersen; Eugenio Paci; Stephen W Duffy; Harry de Koning; John K Field
Journal:  Lancet Oncol       Date:  2017-12       Impact factor: 41.316

3.  Disparities of National Lung Cancer Screening Guidelines in the US Population.

Authors:  Summer S Han; Eric Chow; Kevin Ten Haaf; Iakovos Toumazis; Pianpian Cao; Mehrad Bastani; Martin Tammemagi; Jihyoun Jeon; Eric J Feuer; Rafael Meza; Sylvia K Plevritis
Journal:  J Natl Cancer Inst       Date:  2020-11-01       Impact factor: 13.506

4.  Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized.

Authors:  Danh Pham; Shruti Bhandari; Christina Pinkston; Malgorzata Oechsli; Goetz Kloecker
Journal:  Clin Lung Cancer       Date:  2019-09-26       Impact factor: 4.785

5.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Sheena Patel; Jeffrey P Kanne; Linda S Kinsinger; Renda Soylemez Wiener; Guy Soo Hoo; Frank C Detterbeck
Journal:  Chest       Date:  2018-02-17       Impact factor: 9.410

Review 6.  American Cancer Society lung cancer screening guidelines.

Authors:  Richard Wender; Elizabeth T H Fontham; Ermilo Barrera; Graham A Colditz; Timothy R Church; David S Ettinger; Ruth Etzioni; Christopher R Flowers; G Scott Gazelle; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Daniel C Sullivan; William Travis; Louise Walter; Andrew M D Wolf; Otis W Brawley; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2013-01-11       Impact factor: 508.702

7.  Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.

Authors:  Olaide Y Raji; Stephen W Duffy; Olorunshola F Agbaje; Stuart G Baker; David C Christiani; Adrian Cassidy; John K Field
Journal:  Ann Intern Med       Date:  2012-08-21       Impact factor: 25.391

8.  Proportion of Never Smokers Among Men and Women With Lung Cancer in 7 US States.

Authors:  David A Siegel; Stacey A Fedewa; S Jane Henley; Lori A Pollack; Ahmedin Jemal
Journal:  JAMA Oncol       Date:  2021-02-01       Impact factor: 31.777

9.  Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.

Authors:  Kevin Ten Haaf; Jihyoun Jeon; Martin C Tammemägi; Summer S Han; Chung Yin Kong; Sylvia K Plevritis; Eric J Feuer; Harry J de Koning; Ewout W Steyerberg; Rafael Meza
Journal:  PLoS Med       Date:  2017-04-04       Impact factor: 11.069

10.  Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.

Authors:  M Patricia Rivera; Hormuzd A Katki; Nichole T Tanner; Matthew Triplette; Lori C Sakoda; Renda Soylemez Wiener; Roberto Cardarelli; Lisa Carter-Harris; Kristina Crothers; Joelle T Fathi; Marvella E Ford; Robert Smith; Robert A Winn; Juan P Wisnivesky; Louise M Henderson; Melinda C Aldrich
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

View more
  6 in total

1.  Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.

Authors:  Iakovos Toumazis; Koen de Nijs; Pianpian Cao; Mehrad Bastani; Vidit Munshi; Kevin Ten Haaf; Jihyoun Jeon; G Scott Gazelle; Eric J Feuer; Harry J de Koning; Rafael Meza; Chung Yin Kong; Summer S Han; Sylvia K Plevritis
Journal:  JAMA Oncol       Date:  2021-12-01       Impact factor: 33.006

2.  Use and Outcomes of Low-Dose CT Scan Lung Cancer Screening in the Medicare Population.

Authors:  Paul F Pinsky; Eric Miller
Journal:  Chest       Date:  2022-03-29       Impact factor: 10.262

3.  Effect of Incidental Findings Information on Lung Cancer Screening Intent: a Randomized Controlled Trial.

Authors:  Stephen D Clark; Daniel S Reuland; Alison T Brenner; Daniel E Jonas
Journal:  J Gen Intern Med       Date:  2022-02-02       Impact factor: 6.473

4.  Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.

Authors:  Debra P Ritzwoller; Rafael Meza; Nikki M Carroll; Erica Blum-Barnett; Andrea N Burnett-Hartman; Robert T Greenlee; Stacey A Honda; Christine Neslund-Dudas; Katharine A Rendle; Anil Vachani
Journal:  JAMA Netw Open       Date:  2021-10-01

5.  National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening-Eligible Patients.

Authors:  Rafael Meza; Jihyoun Jeon; Evelyn Jimenez-Mendoza; Yoonseo Mok; Pianpian Cao; Kristie L Foley; Caroline Chiles; Jamie S Ostroff; Paul M Cinciripini; Jennifer Minnix; Nancy A Rigotti; Jennifer S Haas; Kathryn Taylor; Randi M Williams; Benjamin A Toll; Anne M Joseph
Journal:  JTO Clin Res Rep       Date:  2022-06-03

6.  Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort.

Authors:  Raymond U Osarogiagbon; Wei Liao; Nicholas R Faris; Meghan Meadows-Taylor; Carrie Fehnel; Jordan Lane; Sara C Williams; Anita A Patel; Olawale A Akinbobola; Alicia Pacheco; Amanda Epperson; Joy Luttrell; Denise McCoy; Laura McHugh; Raymond Signore; Anna M Bishop; Keith Tonkin; Robert Optican; Jeffrey Wright; Todd Robbins; Meredith A Ray; Matthew P Smeltzer
Journal:  J Clin Oncol       Date:  2022-03-08       Impact factor: 50.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.